Market Overview

8 Biggest Price Target Changes For Monday

Share:
Related TROV
Benzinga's Daily Biotech Pulse: EDAP Device Gets FDA Nod, Ampliphi Presents Positive Data, Agile To Cut Jobs
Benzinga's Daily Biotech Pulse: Johnson & Johnson to Dispose Sterilization Products Business, Mixed Results From Protesostasis' Cystic Fibrosis Study
Trovagene on go with mid-stage study of PCM-075 in mCRPC; shares up 2% (Seeking Alpha)
Related NVDA
A Look Back At What's Happened To Each Sector Through The First Half Of 2018 (Part 1)
What The Latest Steam Gaming Data Means For AMD, Nvidia
48 DGI Stocks Selected For Earnings Growth And Fundamental Strength (Seeking Alpha)

 

  • Credit Suisse lowered the price target on Bristol-Myers Squibb Co (NYSE: BMY) from $86 to $63. Bristol-Myers Squibb shares closed at $63.28 on Friday.
  • Jefferies boosted the price target for NVIDIA Corporation (NASDAQ: NVDA) from $56 to $69. NVIDIA shares closed at $58.20 on Friday.
  • Goldman Sachs boosted the price target for BlackRock, Inc. (NYSE: BLK) from $390 to $400. BlackRock shares closed at $374.75 on Friday.
  • Cantor Fitzgerald raised the price target on TrovaGene Inc (NASDAQ: TROV) from $5 to $7. TrovaGene shares closed at $5.20 on Friday.
  • Citi increased Raptor Pharmaceutical Corp. (NASDAQ: RPTP) price target from $6 to $8. Raptor Pharmaceutical shares closed at $6.89 on Friday.
  • CLSA increased Reynolds American, Inc. (NYSE: RAI) price target from $52 to $54. Reynolds American shares closed at $48.92 on Friday.
  • UBS raised Ferrari N.V. (NYSE: RACE) price target from $50 to $53. Ferrari shares closed at $46.88 on Friday.
  • Credit Suisse raised the price target for Merck & Co., Inc. (NYSE: MRK) from $62 to $73. Merck shares closed at $63.86 on Friday.

Latest Ratings for TROV

DateFirmActionFromTo
Jun 2018Maxim GroupUpgradesHoldBuy
Nov 2017Maxim GroupDowngradesBuyHold
Mar 2017PiperJaffrayDowngradesNeutralUnderweight

View More Analyst Ratings for TROV
View the Latest Analyst Ratings

Posted-In: Price Target ChangesPrice Target Analyst Ratings

 

Related Articles (BLK + BMY)

View Comments and Join the Discussion!